These include: Nausea, vomiting, and diarrhoea (very common, especially during dose escalation) Reduced appetite and abdominal discomfort Constipation Risk of hypoglycaemia when used with insulin or sulphonylureas Pancreatitis and gallbladder disease have been reported Thyroid C-cell tumours have been observed in animal studies, though the relevance to humans is unknown Important safety considerations when using both treatments include: Mounjaro can reduce the effectiveness of oral contraceptives due to delayed gastric emptying
The same study described the mechanism as compound-specific , and the successful semaglutide system depends on close co-formulation, local concentration, tablet erosion, administration conditions, and a heavily characterized drug molecule
Individuals who want to achieve a slow and sustainable weight loss instead of rapid weight loss with standard doses
Grab them while you're here
Well, given the many post we have here, most GP's definitely don't have a clue, especially where B12 deficency and PA is concerned...and thyroid issues...and autoimmune conditions...and, well...evidence on all the forums here at HU
